DVCon U.S. 2023 Announces Keynote Speaker 9-02-2023, 00:42

2ONE Labs and Performance Plus Marketing, sellers of 2ONE Nicotine Pouches, Allege Fraud and Seek Damages in 'Zone' Trademark Infringement Case Against Imperial Brands 8-10-2024, 06:03

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26